private:neurotezinc.-2
|
1506083
|
May 30th, 2019 12:00AM
|
Neurotez, Inc.
|
269
|
6.00
|
Open
|
Biotechnology
|
May 30th, 2019 01:46PM
|
May 30th, 2019 01:46PM
|
Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim.
|
Open
|
|
Open
|
990 Highway 22, Suite 200A
|
Bridgewater
|
NJ
|
US
|
08807
|
|
Neurotez, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:neurotezinc.-2
|
1506083
|
Mar 26th, 2018 12:00AM
|
Neurotez, Inc.
|
230
|
6.00
|
Open
|
Biotechnology
|
Mar 26th, 2018 05:24PM
|
Mar 26th, 2018 05:24PM
|
|
Open
|
|
|
|
|
|
|
|
|
Neurotez, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:neurotezinc.-2
|
1506083
|
Feb 17th, 2018 12:00AM
|
Neurotez, Inc.
|
195
|
6.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim.
|
|
|
|
|
|
|
|
|
|
Neurotez, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:neurotezinc.-2
|
1506083
|
Feb 16th, 2018 12:00AM
|
Neurotez, Inc.
|
195
|
6.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim.
|
|
|
|
|
|
|
|
|
|
Neurotez, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:neurotezinc.-2
|
1506083
|
Feb 15th, 2018 12:00AM
|
Neurotez, Inc.
|
195
|
6.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim.
|
|
|
|
|
|
|
|
|
|
Neurotez, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:neurotezinc.-2
|
1506083
|
Feb 14th, 2018 12:00AM
|
Neurotez, Inc.
|
195
|
6.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim.
|
|
|
|
|
|
|
|
|
|
Neurotez, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:neurotezinc.-2
|
1506083
|
Feb 13th, 2018 12:00AM
|
Neurotez, Inc.
|
195
|
6.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim.
|
|
|
|
|
|
|
|
|
|
Neurotez, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:neurotezinc.-2
|
1506083
|
Feb 12th, 2018 12:00AM
|
Neurotez, Inc.
|
195
|
6.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim.
|
|
|
|
|
|
|
|
|
|
Neurotez, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:neurotezinc.-2
|
1506083
|
Feb 11th, 2018 12:00AM
|
Neurotez, Inc.
|
195
|
6.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim.
|
|
|
|
|
|
|
|
|
|
Neurotez, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:neurotezinc.-2
|
1506083
|
Feb 10th, 2018 12:00AM
|
Neurotez, Inc.
|
195
|
6.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim.
|
|
|
|
|
|
|
|
|
|
Neurotez, Inc.
|
|
Pharmaceuticals & Biotechnology
|